TTirecat Health
Tirecat Health is a Barcelona-based medical polymer company and spin-off of the Catalan Institute of Nanoscience and Nanotechnology (ICN2/CSIC), developing bioinspired, biocompatible adhesive membranes with antimicrobial and regenerative properties for chronic and severe wounds. Its first product, PyroH, targets diabetic foot ulcers, venous ulcers and burns, and is claimed to accelerate tissue regeneration by up to 40% versus conventional therapies while preventing infection. It closed a first round of €170,000 from Grow Venture Partners in 2025, was named best Deep Tech startup at Transfiere 2025, and has signalled plans to raise around €1.6M as it moves toward clinical trials.
SectorsHealthtech & Bio, Medtech, Deeptech & Hardware, Nanotechnology, Regenerative Medicine
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Founders
A
Alex Cánovas
CEO
S
Salvio Suárez-García
Co-founder & CTO
Global models 4
TTissium
France · tissium.com ↗
Spun out of academic research, it develops biocompatible, bioinspired polymer adhesives for tissue repair and aims to commercialise them as regulated medical devices.
$150M+Comparable
CCutiss
Switzerland · cutiss.swiss ↗
University spin-off developing regenerative skin substitutes for severe burns and chronic skin wounds, sold as a regulated therapy to hospitals.
$80MComparable
KKerecis
Iceland · www.kerecis.com ↗
Venture-backed maker of biologic regenerative wound membranes with natural antimicrobial properties for diabetic foot ulcers, venous ulcers and burns, later acquired by Coloplast.
$60M+Comparable
C
Cohera Medical
United States
University spin-out that commercialised synthetic biocompatible polymer tissue adhesives as regulated surgical and wound-closure devices.
$60MComparable
In the same niche 72 others
See all in the Start-ups Map →
AAnaconda Biomed
Sant Cugat del Vallès
Series C (estimated) · €90.1M
IINBRAIN Neuroelectronics
Barcelona
Series B (estimated) · €84.5M
OOverture Life
Madrid
Venture Debt · €71.2M
M
Medlumics
Madrid
No stage disclosed · €57.8M
AAortyx
Barcelona
Series A · €16.9M
NNuubo
Madrid
Series B (estimated) · €16.3M
Notes: Most funded first
Investors 1
Open as list →
Funding rounds 1
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-30 | Pre-seed (estimated) | €170K | Grow Venture Partners |
News 3
Open as list →| Published | Article |
|---|---|
| 2025-04-22 |
Imitating nature to improve health ↗
Atalayar
2025-04-22 |
| 2025-02-28 |
Tirecat Health prevé captar 1,6 millones para regenerar heridas crónicas ↗
The New Barcelona Post
2025-02-28 |
| 2025-02-16 |
ICN2 spin-off Tirecat Health Receives €170,000 to Develop Regenerative Membranes for Human Skin ↗
ICN2
2025-02-16 |